{
  "trial_id": "NCT02894723",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Stage 1 hypertensive patients",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "None to two risk factors",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "BMI between 25 to 32",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Use of any drug that may affect nitric oxide synthesis and/or blood pressure values",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Diabetes mellitus",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "The patient is a 3-day-old Asian female infant with uncomplicated neonatal jaundice. She does not have any exclusion criteria that would make her ineligible for the trial.",
  "_meta": {
    "topic_id": "39",
    "trial_id": "NCT02894723",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}